AVEO Pharmaceuticals, Inc. (AVEO)

[Biotech Pharmer]

The writing's on the wall. From MesaBoogie on ST:
"From October 2018 to August 2019, Sora was remarkably consistent: one-third of the nine patients on therapy discontinued therapy, one-third of those alive who had discontinued therapy died, and the overall number of deaths increased by one-third.
Tivo had only 1 of 34 (3%) on therapy discontinue treatment, but had 36% (comparable to Sora’s 33%)of patients who had discontinued therapy die, but the overall number of deaths increased by only 16%."